clinical trial · NCT06670651
LinkSymphoKnee (LSK) Total Knee Replacement System Study - Ultra-congruent (UC)
LinkBio Corp.·—·enrolling by invitation·n = 600
Osteoarthritis (OA) of the KneeFractureRheumatoid Arthritistotal knee arthroplasty device
brief summary
To collect information about implant performance and patient clinical outcomes in patients undergoing primary total knee arthroplasty with the LinkSymphoKnee total knee replacement system with ultra-congruent tibial bearing surface.
started
Mar 21, 2025
primary completion
Dec 1, 2031
completion
Dec 1, 2031
last updated
Jun 10, 2025
detailed description
The study will collect outcomes data on up to 600 patients from up to 3 sites using a legally marketed device according to its labeled intended use.
The study will collect:
1. KOOS-JR 2. Knee Society Score (KSS), 2011 3. PROMIS Global Health 4. PROMIS Physical Function 5. PROMIS Pain Interference 6. Surgery Satisfaction 7. Forgotten Joint Score 8. Radiographic findings 9. Revisions.
Radiographic evaluations will be done through postoperative year 2. Other outcomes will be evaluated up to postoperative year 5.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol